TTrialPathMatch Me to Trials
← Back to trials
RecruitingSpondyloarthritis, AxialArthritis, Psoriatic

Influence of Sodium Intake in spondyLoarthriTes

Eligible age

18–80 yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The aim of the SALT study is to analyze the relationship between dietary sodium intake and disease activity in patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis.

Sponsor: Centre Hospitalier Universitaire de Besancon

You may qualify if…

  • ✓ patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis
  • ✓ women who have been menopausal for at least 24 months, surgically sterilized, or, for women of childbearing potentiale, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double-barrier method, contraceptive patches)

You may not qualify if…

  • ✕ patient treated by cyclosporine, diuretics, angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists.
  • ✕ current treatment with an anti-IL-17A agent (secukinumab or ixekizumab or bimekizumab or brodalumab) or with an anti-IL23 agent (ustekinumab, guselkumab, risankizumab or tildrakizumab) or previous treatment less than 6 months old.
  • ✕ patients on systemic corticosteroids with corticosteroid therapy \> 10 mg prednisone equivalent
  • ✕ pregnant woman

Source: ClinicalTrials.gov · NCT06259890 · last updated 2025-07-09

Influence of Sodium Intake in spondyLoarthriTes · TrialPath